The $50 billion French pharmaceutical giant Sanofi is quickly converting its operations to an AI-first model. Thousands of employees utilize its automated app Plai, powered by German startup Aily ...

Sanofi has returned to Nurix Therapeutics for another autoimmune candidate, paying $15 million and committing up to $465 million for exclusive rights to a degrader of a once-undruggable ...